Panel Discussion: Leveraging Cross-Sector Partnerships: How Small Biotechs Navigate Big Pharma Interest in Dermatology
- What data packages de-risk acquisition or licensing for large pharma?
- How do biotechs time interactions with BD teams and investment banks?
- What distinguishes “interesting science” from investable clinical programs?